Vyro Bio
0 followers
‌
Vyro develops oncolytic viruses designed to target CNS tumors, based on pioneering research on the oncolytic properties of the Zika Virus.
Industries
Headquarters
Employees
Links
Org chart
Hugo Cabrera
CEO & Co-Founder
Hugo Cabrera
Collapse
Carolini Kaid
Co-founder
Flávia Santoro
Marketing Assistant
Gabriela Minamoto
Administrative Assistant
Fabiane Honório
Laboratory Technician
